Stamatios Lerakis, MD, FACC

Clinical Trials

• Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

Media Releases

Get to know Cardiologist Dr. Stamatios Lerakis, who serves patients in New York, New York.

Helping patients maintain a heart-healthy life, Dr. Lerakis is a recognized multimodality cardiac imager & a national and international expert in imaging for structural and valve interventions. 

On September 1st, 2018, he joined the Zena and Michael A. Wiener Cardiovascular Institute, full time faculty, in the role of Professor of Medicine and Director of Noninvasive Cardiology for  The Lauder Family Cardiovascular Center of Mount Sinai Heart & as Director of Imaging for Structural and Valve Interventions for the Mount Sinai Health System. 

Holding academic appointments, Dr. Lerakis serves as a Professor of Medicine (Cardiology) and as a Professor of Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai. 

Growing up in the village of Kalamoti in the island of Chios, it was there that Dr. Lerakis finished high school. He then graduated with his medical degree from the Medical School of Athens and went to the United States for his medical training. 

He continued doing clinical research in nuclear cardiology at Mount Sinai Hospital. Subsequently, he did his internal medicine training in the Presbyterian Medical Center of Philadelphia, and then completed a year of fellowship in critical care at Brown University. 

Thereafter, Dr. Lerakis completed his fellowship in cardiology at the University of Texas Medical Branch at Galveston, and then did a one-year fellowship in echocardiography at Emory University. 

After his fellowship, he stayed on as faculty in the Division of Cardiology at Emory University where he was a Professor of Medicine, Radiology and Imaging Sciences, the Director of Imaging for the Structural and Valve Interventions in Emory Healthcare, the Medical Director for Nuclear Cardiology and Cardiac MRI at Emory University Hospital and Emory Clinic, and as the Fellowship Program Director for the Advanced Cardiovascular Imaging Fellowship (CMR and CCT).

Level 3 trained and certified in all cardiovascular imaging modalities, Dr. Lerakis is board-certified in cardiovascular disease by the American Board of Internal Medicine.

Moreover, he is board-certified in cardiovascular computed tomography by the Certification Board of Cardiovascular Computed Tomography™ (CBCCT™), in cardiovascular magnetic resonance by the Certification Board of Cardiovascular Magnetic Resonance (CBCMR), in nuclear cardiology by the Certification Board of Nuclear Cardiology, and in echocardiography by the National Board of Echocardiography.

Among his professional affiliations, Lerakis is a Fellow of the American College of Cardiology (FACC) and a member of the American College of Chest Physicians.

Cardiology is a branch of medicine that deals with the disorders of the heart, as well as some parts of the circulatory system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Cardiologists are doctors who diagnose, assess, and treat patients with diseases and defects of the heart and blood vessels (the cardiovascular system).

An expert in his field, Dr. Lerakis has been regularly invited to faculty and guest lecturer in multiple national and international conferences. He has also been the PI and Co-PI in multiple structural and valve trials, and has conducted more than 200 publications. 

His various accolades include 2017 Distinguished Physician Award, Department of Medicine at the Emory University School of Medicine; 2010 Gerald Pohost Journal Cardiac Magnetic Resonance Best Manuscript Award, the Society of Cardiac Magnetic Resonance; 2001 Excellence in Teaching, Emory University School of Medicine; and 1982 Scholarship-Patera, National Philanthropic Organization in Athens, Greece.

Happily married, Dr. Lerakis and his wife, Ioanna Dafermou, have a son named Alexandros. 

Recommended Articles

• A New Form of Spaghetti Has Been Designed to Reduce the Risk of Heart Disease

  Scientists have developed ‘super spaghetti’, a variant of the normal form made from barley flour and this new form of noodles is supposed to reduce the risk of heart disease. Super spaghetti was developed by the scientists in Italy and Spain and the report is published in, Journal of...

• Angina Pectoris: What are the Symptoms, Causes, and Treatment?

  Angina pectoris is a symptom of a coronary artery disease which causes chest pain due to less blood flow to the heart muscle. Angina pectoris is also known as angina, and this problem can be a recurring issue or a sudden acute issue. Angina pectoris can be defined as pressure, stiffness, tightness...

• What You Need to Know About Coronary Heart Disease (CHD)

  What is CHD?Coronary heart disease (CHD) is the disease that develops when there is an insufficient oxygen supply to the heart muscle by the coronary arteries. The most common reason for this is atherosclerosis of the coronary arteries with cholesterol plaques formation and narrowing of the arterial...

• What Is Ischemia? Treatment for Acute or Chronic Ischemia

  What is ischemia?Ischemia is the medical term used to describe a lack of blood flow to certain organs or body parts. Since the blood carries oxygen and other necessary nutrients to parts of the body, when blow flow is reduced these body parts do not receive the adequate amount of oxygen and...

• Are There Benign and Malignant Tumors of the Heart?

  It is a well-known fact that in the body, in various tissues due to various reasons, neoplasms sometimes appear in the form of tumor growths. The heart is not an exception. The tumor growth can be benign and malignant. Therefore, there are two types of the heart tumors.Benign tumors These do not...

• What Is Tachypnea?

  Introduction Tachypnea is a medical term, which means rapid and shallow breathing. This condition is often confused with hyperventilation, which is another type of abnormal breathing that is characterized by rapid but deep breathing. Both conditions are caused by carbon dioxide buildup in the...